Profile

John M. Burkart, M.D.Wake Forest School of Medicine

Doctor Rating

No Rating Available
Why No Ratings?

John M. Burkart, M.D.

Professor,

Clinical Interests

Nephrology, Peritoneal Dialysis, Kidney Disease, Hemodialysis, Clinical Nephrology

Contact Information

Returning Patient Appointments: 336-716-3963
Department: 336-716-4650

Insurance Accepted »

Media Medical Expert »

Education & Training

  • B.S., University of Illinois Administration, 1974
  • M.D., Rush Medical College, 1979
  • Internship, Medicine, NC Baptist Hospital, 1980
  • Residency, Medicine, NC Baptist Hospital, 1982
  • Fellowship, NC Baptist Hospital, 1984

Board Certifications

  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Nephrology

Memberships

  • Int'L Society Peritoneal Dialy
  • Am Soc Of Nephrology

NPI Number

  • 1669457891
John M. Burkart, M.D.

Doctor Rating

No Rating Available
Why No Ratings?

John M. Burkart, M.D.

Professor, Nephrology

Research Interests

Peritoneal Dialysis; Kidney Failure, Chronic; Renal Dialysis; Hemodialysis, Home; Peritoneal Dialysis, Continuous Ambulatory
More »

Contact Information

Academic: 336-716-3963 | Department: 336-716-4650

Media Medical Expert »

Recent Publications

Peritoneal dialysis university for surgeons: a peritoneal access training program. Crabtree JH, Penner T, Armstrong SW, Burkart J.. Perit Dial Int. 2016;36(2):177-181.

The effect of increased frequency of hemodialysis on volume-related outcomes: a secondary analysis of the frequent hemodialysis network trials. Raimann JG, Chan CT, Daugirdas JT, Depner T, Gotch FA, Greene T, Kaysen GA, Kliger AS, Kotanko P, Larive B, Lindsay R, Rocco MV, Chertow GM, Levin NW, Burkart J, Moossavi S, et al.. Blood Purif. 2016;41(4):277-286.

Finding the right hemodialysis vascular access in the elderly: a patient-centered approach. Murea M, Burkart J.. J Vasc Access. 2016;17(5):386-391.

Intensive hemodialysis, left ventricular hypertrophy, and cardiovascular disease. McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL.. Am J Kidney Dis. 2016;68(5 Suppl 1):S5-S14.

Intensive hemodialysis and potential risks with increasing treatment. Kraus MA, Kansal S, Copland M, Komenda P, Weinhandl ED, Bakris GL, Chan CT, Fluck RJ, Burkart JM.. Am J Kidney Dis. 2016;68(5 Suppl 1):S51-S58.

Intensive hemodialysis, blood pressure, and antihypertensive medication use. Bakris GL, Burkart JM, Weinhandl ED, McCullough PA, Kraus MA.. Am J Kidney Dis. 2016;68(5 Suppl 1):S15-S23.

Survey of home hemodialysis patients and nursing staff regarding vascular access use and care. Spry LA, Burkart JM, Holcroft C, Mortier L, Glickman JD.. Hemodial Int. 2015;19(2):225-234.

Anemia management practice patterns in small dialysis organizations following implementation of the prospective payment system. Burkart JM, Beaubrun AC, Olson KA, Park GS, Yue SV, Rubin RJ.. Clin Nephrol. 2015;84(4):206-213.

Risk of catheter-related bloodstream infection in elderly patients on hemodialysis. Murea M, James KM, Russell GB, Byrum GV III, Yates JE, Tuttle NS, Bleyer AJ, Burkart JM, Freedman BI.. Clin J Am Soc Nephrol. 2014;9(4):764-770.

Comparative outcomes between continuous ambulatory and automated peritoneal dialysis: a narrative review. Bieber SD, Burkart J, Golper TA, Teitelbaum I, Mehrotra R.. Am J Kidney Dis. 2014;63(6):1027-1037.

Thoughts on Dr. Karl Nolph [in memoriam]. Burkart J.. Perit Dial Int. 2014;34(6):581.

Hemoglobin stability and patient compliance with darbepoetin alfa in peritoneal dialysis patients after the implementation of the prospective payment system. Pirkle JL Jr, Paoli CJ, Russell G, Petersen J, Burkart J.. Clin Ther. 2014;36(11):1665-1674.

Early trends from the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS). Brunelli SM, Monda KL, Burkart JM, Gitlin M, Neumann PJ, Park GS, Symonian-Silver M, Yue S, Bradbury BD, Rubin RJ.. Am J Kidney Dis. 2013;61(6):947-956.

Treatment options for renal cell carcinoma in renal allografts: a case series from a single institution. Swords DC, Al-Geizawi SM, Farney AC, Rogers J, Burkart JM, Assimos DG, Stratta RJ.. Clin Transplant. 2013;27(2):E199-E205.

Hospitalization and mortality rates in small dialysis organizations (SDOS) opting into the dialysis bundle 100% vs 25% [abstract]. Burkart JM, Monda KL, Neumann PJ, Rubin RJ, Bradbury BD.. Am J Kidney Dis. 2013;61(4):A29.

Anemia management using darbepoetin alfa among peritoneal dialysis (PD) patients at Wake Forest Outpatient Dialysis (WFOPD) [abstract]. Pirkle J, Paoli CJ, Russell G, Petersen J, Burkart J.. Am J Kidney Dis. 2013;61(4):A76.

Prevalence of case-mix adjusters among small dialysis organizations (SDOs) [abstract]. Rubin RJ, Burkart JM, Yue S, Gitlin M, Neumann PJ.. Am J Kidney Dis. 2013;61(4):A84.

Risk of catheter-related bloodstream infections in elderly patients on hemodialysis [abstract]. Murea M, James KM, Russell GB, Bleyer AJ, Burkart JM, Freedman BI.. J Am Soc Nephrol. 2013;24(Abstract Suppl):396A.

Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Schiller BM, Yang PC, Rajagopalan S, Burkart J, Moossavi S, Mauck V, Kaufman T, et al.. Circ Cardiovasc Imaging. 2012;5(2):251-261.

Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials. Hall YN, Larive B, Painter P, Kaysen GA, Lindsay RM, Nissenson AR, Unruh ML, Rocco MV, Chertow GM, Burkart J, Moosavi S, Mauck V, Kaufman T, et al.. Clin J Am Soc Nephrol. 2012;7(5):782-794.

Challenges to enrollment and randomization of the Frequent Hemodialysis Network (FHN) Daily Trial. Sergeyeva O, Gorodetskaya I, Ramos R, Schiller BM, Larive B, Raimann JG, Ting GO, Eggers PW, Chertow GM, Levin NW, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, Coppley A, et al.. J Nephrol. 2012;25(3):302-309.

Combination therapy: five days PD and one day HD -- what are the benefits?. Burkart J.. Contrib Nephrol. 2012;178():216-220.

Prospective safety study of bardoxolone methyl in patients with type 2 diabetes mellitus, end-stage renal disease and peritoneal dialysis. Warnock DG, Hebbar S, Bargman J, Burkart J, Davies S, Finkelstein FO, Mehrotra R, Ronco C, Teitelbaum I, Urakpo K, Chertow GM.. Contrib Nephrol. 2012;178():157-163.

The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis. Pierce DA, Williamson JC, Mauck VS, Russell GB, Palavecino E, Burkart JM.. Perit Dial Int. 2012;32(5):525-530.

Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances. Jaber BL, Schiller B, Burkart JM, Daoui R, Kraus MA, Lee Y, Miller BW, Teitelbaum I, Williams AW, Finkelstein FO.. Clin J Am Soc Nephrol. 2011;6(5):1049-1056.

Re-evaluating the Fistula First Initiative in octogenarians on hemodialysis. Vachharajani TJ, Moossavi S, Jordan JR, Vachharajani V, Freedman BI, Burkart JM.. Clin J Am Soc Nephrol. 2011;6(7):1663-1667.

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, Burkart J, Moossavi S, Mauck V, Kaufman T, et al.. Kidney Int. 2011;80(10):1080-1091.

Erythropoietin maximum dose reduction protocol for hemodialysis [abstract]. Hawfield AT, Russell GB, Burkart JM, Chandramohan V.. J Am Soc Nephrol. 2011;22(Abstract Suppl):478A.

Effects of six versus three times per week hemodialysis on depressive affect and mental health: Frequent Hemodialysis Network (FHN) trials [abstract]. Unruh ML, Larive B, Chertow GM, Eggers PW, Garg AX, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, et al.. J Am Soc Nephrol. 2011;22(Abstract Suppl):255A.

Effects of six versus three times per week hemodialysis on physical performance, health and functioning: Frequent Hemodialysis Network (FHN) trials [abstract]. Hall YN, Larive B, Painter PL, Kaysen GA, Lindsay RM, Rocco MV, Burkart J, Moossavi S, Mauck V, Kaufman T, et al.. J Am Soc Nephrol. 2011;22(Abstract Suppl):66A.

Systematic barriers to the effective delivery of home dialysis in the United States: a report from the Public Policy/Advocacy Committee of the North American Chapter of the International Society for Peritoneal Dialysis. Golper TA, Saxena AB, Piraino B, Teitelbaum I, Burkart J, Finkelstein FO, Abu-Alfa A.. Am J Kidney Dis. 2011;58(6):879-885.

Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis. Freedman BI, Shenoy RN, Planer JA, Clay KD, Shihabi ZK, Burkart JM, Sabio H, Byers JR, Russell GB, Bleyer AJ, et al.. Perit Dial Int. 2010;30(1):72-79.

The future of peritoneal dialysis: PD in 2010 and beyond. Burkart J.. Dial Transplant. 2010;39(8):349-353.

Adequacy of peritoneal dialysis. Burkart JM. In: Henrich WL, ed. Principles and practice of dialysis. 4th ed. Philadelphia: Wolters Kluwer Health/Lippincott Wiliams & Wilkins;2009: 241-265.

The future of peritoneal dialysis in the United States: optimizing its use. Burkart J.. Clin J Am Soc Nephrol. 2009;4(Suppl 1):S125-S131.

Academic free-standing vascular access centers: early experience [abstract]. Vachharajani TJ, Moossavi S, Daeihgah P, Jordan JR, Coe MS, Burkart JM, Freedman B.. Semin Dial. 2008;21(1):106.

Re-evaluating the fistula first initiative in octogenarian dialysis patients [abstract]. Vachharajani TJ, Moossavi S, Kaufman TM, Jordan JR, Freedman BI, Burkart JM.. J Vasc Access. 2008;9(Suppl 1):S16-S17.

Role of peritoneal dialysis in the era of the resurgence of home hemodialysis. Burkart J.. Hemodial Int. 2008;12(Suppl 1):S51-S54.

Techniques in peritoneal dialysis. Burkart JM. In: Wilcox CS, ed. Therapy in nephrology & hypertension: a companion to Brenner & Rector's The kidney. 3rd ed. Philadelphia: Saunders/Elsevier;2008: 913-923.

Effect of practice pattern on hemodialysis access thrombosis: the impact of access surveillance [abstract]. Moossavi S, Russell G, Vachharajani T, Burkart J, Freedman B.. J Am Soc Nephrol. 2008;19():901A.

Evaluation of glycated albumin (GA), HbA1c and serum glucose concentrations in diabetic peritoneal (PD) and hemodialysis (HD) patients [abstract]. Shenoy RN, Planer JA, Clay KD, Bleyer AJ, Burkart JM, Cardona CY, Byers JR, Russell GB, Shihabi ZK, Freedman BI, et al.. J Am Soc Nephrol. 2008;19():974A-975A.

Initiation of dialysis therapy. Satko SG, Burkart JM. In: Nissenson AR, Fine RN, eds. Handbook of dialysis therapy. 4th ed. Philadelphia: Saunders/Elsevier;2008: 341-351.

Determination of continuous ambulatory peritoneal dialysis and automated peritoneal dialysis prescriptions. Satko SG, Burkart JM. In: Nissenson AR, Fine RN, eds. Handbook of dialysis therapy. 4th ed. Philadelphia: Saunders/Elsevier;2008: 539-548.

Why is the evidence favoring hemodialysis over peritoneal dialysis misleading? [editorial]. Burkart J.. Semin Dial. 2007;20(3):200-202.

Comparison of dialysis access outcomes in peritoneal dialysis (PD) and hemodialysis (HD) patients at an academic medical center [abstract]. Moossavi S, Moossavi S, Raasch E, Jordan J, Burkat [sic] J [Burkart J].. J Am Soc Nephrol. 2007;18(Abstracts Issue):466A.

Comparison of dialysis outcomes in peritoneal dialysis and hemodialysis patients at an academic medical center [abstract]. Raasch E, Moossavi S, Beekman D, Russell G, Moossavi S, Jordon J, Mauck V, Burkart J.. J Am Soc Nephrol. 2007;18(Abstracts Issue):477A.

Comparison of mean Kt/v and anuric Kt/v in adult peritoneal dialysis (PD) patients based on weight [abstract]. Saran A, Moossavi S, Hutchens M, Russell G, Burkart J.. J Am Soc Nephrol. 2007;18(Abstracts Issue):477A.

Comparison of mean Kt/v and clinical outcomes in an adult peritoneal dialysis (PD) population based on body mass index (BMI) (kg/m2) [abstract]. Saran AM, Moossavi S, Russell G, Kaufman T, Burkart J.. J Am Soc Nephrol. 2007;18(Abstracts Issue):477A.

Comparison of clinical outcomes in an adult PD population with a body mass index (BMI) greater than 30 kg/m2 based on the placement of abdominal or presternal peritoneal dialysis catheters [abstract]. Saran A, Moossavi S, Russell G, Mauck V, Burkart J.. J Am Soc Nephrol. 2007;18(Abstracts Issue):903A.

Comparison of patient turn over/loss in an academic hemodialysis (HD) unit and peritoneal dialysis (PD) unit [abstract]. Moossavi S, Moossavi S, Coe M, Burkart J.. J Am Soc Nephrol. 2007;18(Abstracts Issue):918A.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Nephrology

Clinical Interests

Nephrology, Peritoneal Dialysis, Kidney Disease, Hemodialysis, Clinical Nephrology
John M. Burkart, M.D.

John M. Burkart, M.D.

Professor, Nephrology

CP concern for questions/worries
5
CP efforts to include in decisions
5
CP explanations of prob/condition
5
CP spoke using clear language
5
Friendliness/courtesy of CP
5
Likelihood of recommending CP
5
Patients' confidence in CP
5
Time CP spent with patient
5
Wait time at clinic
5

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.